D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ACET holding history
Adicet Bio, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACET overviewAll 13F holders of ACETFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −22,199−100.0% | Sold out | Holders |
| Q2 2025 | 22,199 | $13.5K | <0.1% | −483,270−95.6% | Reduced | Holders |
| Q1 2025 | 505,469 | $381.6K | <0.1% | −341,595−40.3% | Reduced | Holders |
| Q4 2024 | 847,064 | $814.9K | <0.1% | −70,006−7.6% | Reduced | Holders |
| Q3 2024 | 917,070 | $1.32M | <0.1% | +81,032+9.7% | Added | Holders |
| Q2 2024 | 836,038 | $1.01M | <0.1% | +510,089+156.5% | Added | Holders |
| Q1 2024 | 325,949 | $766.0K | <0.1% | −20,670−6.0% | Reduced | Holders |
| Q4 2023 | 346,619 | $655.1K | <0.1% | +101,746+41.6% | Added | Holders |
| Q3 2023 | 244,873 | $335.5K | <0.1% | +213,419+678.5% | Added | Holders |
| Q2 2023 | 31,454 | $76.4K | <0.1% | −13,151−29.5% | Reduced | Holders |
| Q1 2023 | 44,605 | $256.9K | <0.1% | +44,605 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −112,355−100.0% | Sold out | Holders |
| Q3 2022 | 112,355 | $1.60M | <0.1% | −219,457−66.1% | Reduced | Holders |
| Q2 2022 | 331,812 | $4.84M | <0.1% | +110,685+50.1% | Added | Holders |
| Q1 2022 | 221,127 | $4.42M | <0.1% | +8,670+4.1% | Added | Holders |
| Q4 2021 | 212,457 | $3.72M | <0.1% | +168,586+384.3% | Added | Holders |
| Q3 2021 | 43,871 | $344.0K | <0.1% | −28,163−39.1% | Reduced | Holders |
| Q2 2021 | 72,034 | $741.0K | <0.1% | +39,548+121.7% | Added | Holders |
| Q1 2021 | 32,486 | $425.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.